To 2020, the participation of biological medicines in the entire pharmaceutical market will increase to nearly 30%. The veterinary market will systematically follow these trends. As in people, we see a clear upward trend in the epidemiology of civilization diseases. In many cases, these are autoimmune diseases. Biological drugs based on stem cells can play a key role here. In general, the market situation is simply an invitation to develop such technology as Bioceltix – biotechnologia.pl.
